Insulin and glucagon-like peptide1 receptor agonist combination therapy in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials - Maiorino, M I; Chiodini, P; Bellastella, G (Diabetes Care, 2017)
et al.